CE approved test
Book a COVID-19 Antigen Rapid test
Needing to travel to a Country that accepts antigen tests? Need to know quickly whether the symptoms you have are COVID-19? Looking to return to work with peace of mind?
Booking a COVID-19 Antigen Rapid test with REMEDI HEALTH is quick. Just pick a time and date that suits you. The testing process should last no more than 5 minutes. Once you have booked a time, if you’re symptomatic we will call you to agree the most appropriate location for testing, which could be at your home or in your car.
If there is no available slot on the day you require testing then please call the clinic on 01962 396695, as we may be able to arrange an out-of-hours appointment.
Each test is £120.00 (£150.00 out of hours, weekends and bank holidays. Book online and you can pay the supplement when in clinic).
Please select a date and time from the calendar and enter your details.
If you are experiencing any COVID-19 symptoms you must self-isolate.
Should you require an occupational testing strategy for your place of work then please contact or call us 01962 396695 or 07899 967040.
back to work
COVID-19 antigen rapid test: how it works
A simple nasal swab test is all that’s required to diagnose active COVID-19 infections, facilitating appropriate containment and reducing further spread of disease. A negative result may be a requirement for travel or work.
We provide healthcare professional swab testing to ensure that the sample obtained is more likely to return an accurate result. The tests we use are CE approved for healthcare professional use only.
We use a number of different manufacturers of COVID-19 Antigen Rapid Tests including those required by the French authorities to deliver high-precision results in just a few minutes. Our tests also meet the antigen requirements for all other countries where this type of test is acceptable. Our test is approved by WHO. The tests cost less than a PCR test and conserves laboratory capacity.
The COVID-19 Antigen Rapid Test – a chromatographic lateral flow immunoassay – checks for protein fragments from the virus and thus for its direct, physical presence in the body. It is performed using a swab from the nasopharynx. This is extracted in a buffer solution and then pipetted onto the test cassette. A qualitative result is ready in 15 minutes.
COVID-19 RT-PCR Test Also Available
CE approved test + approved for France, Germany, Italy and USA and others
COVID-19 antigen rapid testing
These tests can be used for ‘fit to fly ‘ certificates.
As part of your company’s strategy to help keep your employees and workplaces COVID secure and operational, the COVID-19 instant Antigen test is an affordable, fast and accurate way to determine the infection status of employees onsite or returning to the workplace. If you require an oocupational health testing strategy then please contact us to discuss.
Alternatively you may want to get your child back to school, student back home or need to return to work.
Fast testing will be a vital part of the response to the COVID-19 pandemic, particularly during the Winter when it will be difficult to differentiate between common colds, flu and COVID-19.
What’s the difference between the COVID-19 Antigen Test and the COVID-19 PCR test?
The COVID-19 RT-PCR test detects the virus’ genetic material (RNA) within a positive sample. A laboratory process is required to test the sample and can take up to 72 hrs to return a result from the time of sample collection (NHS). Our PCR tests usually return a result within 36 hours (the night following the day of testing).
- The diagnostic sensitivity of our tests all meet the MHRA Target Product Profile requirements. The SD BIOSENSOR STANDARD Q COVID-19 Ag Test has a senstivity of 96.52%
- The diagnostic specificity is 99.68%.
We have a range of other tests for different purposes.
There is always a residual risk of a false-negative result, when in doubt, a PCR test should be carried out to confirm negative results.
Our rapid tests use lateral flow chromatographic immunoassay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in human naso and oropharyngeal samples. The test is intended to be used as an aid in the diagnosis of infections with SARS-CoV-2.